Psychosocial Aspects of Life of Patients with Psoriasis in the Czech Republic
Authors:
S. Gkalpakiotis; P. Arenberger; E. Adenubiová
Authors‘ workplace:
Dermatovenerologická klinika 3. LF UK a FNKV
přednosta prof. MUDr. Petr Arenberger, DrSc., MBA
Published in:
Čes-slov Derm, 88, 2013, No. 4, p. 189-196
Category:
Practice
Overview
Psoriasis is a chronic inflammatory skin disease that significantly impairs quality of life in a similar way like other serious diseases (diabetes mellitus, hypertension, cancer). The aim of this research was to determine the number of patients with psoriasis who are in out-patient care of dermatologists, their basic characteristics, and to evaluate the characteristics of topical therapy, compliance, financial effects of copayment and influence on the quality of life of patients. Methodology was chosen through a random selection of personal interviewing of doctors and patients across the country. The study included private dermatologists and patients with psoriasis on topical treatment. Totally 4 group discussion were held (12 physicians and 18 patients) concurrently with personal questionnaires (70 physicians and 142 patients). Totally 82 physicians and 160 patients participated in the period from May to June 2012. The results were in accordance with other European studies and confirms similar impact of psoriasis on quality of life. The study is so valuable in understanding the complexity of the disease and illuminates not only the relationship between psychological stress and the factors that lead to a deterioration in quality of life, but also helps to understand the importance of educational aid for quality of life with chronic disease. Last but not least, the study helped to assess the impact of socioeconomic status of patient on his treatment adherence.
Key words:
psoriasis – topical therapy – psychological stress – quality of life
Sources
1. BOSCARINO, J. A. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Annals of the New York Academy of Sciences, 2004, 1032, p. 141–153.
2. DUBERTRET, L., MROOWIETZ, U., RANKI, A. et al. European patient perspectives on the impact of psoriasis the EUROPSO patient membership survey. Br. J. Dermatol., 2006, 155, p. 729–736.
3. EGHLILEB, A. M., DAVIES, E. E., FINLAY, A. Y. Psoriasis has a major secondary impact on the lives of family members and partners. Br. J. Dermatol., 2007, 156, p. 1245–1250.
4. ESPOSITO, M., SARACENO, R., GIUNTA, A., MACCARONE, M., CHIMENTI, S. An Italian study on psoriasis and depression. Dermatology, 2006, 212, p. 123–127.
5. FINLAY, A. Y., COLES, E. C. The effect of severe psoriasis on quality of life of 369 patients. Br. J. Dermatol., 1995, 132, p. 236–244.
6. FINZI, A., COLOMBO, D., CAPUTO, A., ANDREASSI, L., CHIMENTI, S., VENA, G., SIMONI, L., SGARBI, S., GIANNETTI, A. FOR THE PSYCHAE STUDY GROUP Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J. Eur. Acad. Dermatol., 2007, 21, p. 1161–1169.
7. FRIED, R. G., FRIEDMAN, S., PARADIS, C. et al. Trivials or terrible? The psychosocial impact of psoriasis. Int. J. Dermatol., 1995, 34, p. 101–105.
8. GINSBURG, J. H., LINK, B. G. Feelings of stigmatization in patients with psoriasis. J. Am. Acad. Dermatol., 1989, 20, p. 53–63.
9. GOWDA, S., GOLDBLUM, O. M., MCCALL, W. V., FELDMAN, S. R. Factors affecting sleep quality in patients with psoriasis. J. Am. Acad. Dermatol., 2010, 63, p. 114–123.
10. GRIFFITHS, C. E. M., RICHARDS, H. L. Psychological influences in psoriasis. Clin. Exp. Dermatol., 2001, 26, p. 338–342.
11. GUPTA, M. A., GUPTA, A. K. Psoriasis and sex: A study of moderately to severely affected patients. Int. J. Dermatol., 1997, 36, p. 259–262.
12. GUPTA, M. A., GUPTA, A. K. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. British Journal of Dermatology, 1998, 5, p. 846–850.
13. KRUEGER, G., KOO, J., LEBWOHL, M. et al. The impact of psoriasis on quality of life: results from a 1998 National Psoriasis Foundation patient-membership survey. Arch. Dermatol., 2001, 137, p. 280–284.
14. KURD, S. K., TROXEL, A. B., CRITS-CHRISTOP, P., GELFAND, J. M. The risk of depression, anxiety and suicidality in patient with psoriasis: a population-based cohort study. Archives of Dermatology, 2010, 146, p. 891–895.
15. O’NEILL, P., KELLY, P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ, 1996, 313, p. 919–921.
16. RAPP, S. R., EXUM, M. L., REBOUSSIN, D. M., FELDMAN, S. R., FLEISCHER, A., CLARK, A. R. The physical, psychological and social impact of psoriasis. Journal of Health Psychology, 1997, 2, p. 525–537.
17. SCHMITT, J., FORD, D. E. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J. Eur. Acad. Dermatol. Venereol., 2010, 8, p. 885–892.
18. WAHL, A., MOUN, T., HANESTAD, B. R. et al. The relationship between dermographic and clinical variables, and quality of life aspects in patients with psoriasis. Qual Life Res., 1999, 8, p. 319–326.
19. ZAGHLOUL, S. S., GOODFIELD, M. J. Objective assessment of compliance with psoriasis treatment. Arch. Dermatol., 2004, 140, p. 408–414.
Labels
Dermatology & STDs Paediatric dermatology & STDsArticle was published in
Czech-Slovak Dermatology
2013 Issue 4
Most read in this issue
- Nail surgery: Introduction, Review on Surgical Techniques and Our Experience in Selected Nail Diseases
- Dermatosurgery and its Crucial Position in the Field of Dermatology and Venereology
- UVA1 in the Management of Dermatoses
- Rare Form of Tinea capitis Profunda Caused by Trichophyton tonsurans in Child